Joe.My.God. LGBT News
CNBC reports:
Regeneron Pharmaceuticals on Monday announced it will acquire “substantially all” of 23andMe’s assets for $256 million.
The drugmaker participated in a bankruptcy auction for 23andMe, a once high-flying genetic testing company that filed for for Chapter 11 bankruptcy protection in March. Regeneron is buying 23andMe’s Personal Genome Service, Total Health and Research Services business lines, according to a release.
Several lawmakers and officials, including the Federal Trade Commission, had expressed concerns about the safety of consumers’ genetic data through 23andMe’s sale process. The privacy ombudsman will present a report on the acquisition to the court by June 10.
Read the full article.
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, the companies said on Monday.
— Reuters Legal (@legal.reuters.com) May 19, 2025 at 8:10 AM